The rise of interest by real estate developers and investor in the life-sciences segment has led to it potentially now constituting an asset class in its own right, in the same way as offices, logistics… To find out just what this segment means to the market, we conducted a ‘cross interview’ with Michel Leemhuis, CEO...
We use cookies to optimise your user experience on our website. More information
These cookies are needed to ensure the website/platform works properly and to facilitate navigation. By continuing to browse, you agree to accept the use of required cookies.
These cookies allow us to anonymously track visits and traffic so that we can measure and improve the performance of our platform/website.
We use these cookies for marketing purposes. These allow us to optimise advertisements based on your surfing behaviour and to continuously improve our relationship with website visitors.
My favourites
You have not yet selected any favourites. Review what we have on offer and click on the heart to add a property to your favourites.
